本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kymera Therapeutics, Inc.

83.29
+3.814.79%
盘前83.600.3100+0.37%06:03 EDT
成交量:131.39万
成交额:1.09亿
市值:68.00亿
市盈率:-22.57
高:86.06
开:80.20
低:80.20
收:79.48
52周最高:103.00
52周最低:19.45
股本:8,164.24万
流通股本:5,462.66万
量比:1.84
换手率:2.41%
股息:- -
股息率:- -
每股收益(TTM):-3.6900
每股收益(LYR):-3.6900
净资产收益率:-25.78%
总资产收益率:-15.87%
市净率:4.30
市盈率(LYR):-22.57

数据加载中...

2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]